HNRNPH1P3

Across TCGA pan-cancer cohorts, HNRNPH1P3 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of HNRNPH1P3’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where HNRNPH1P3 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types HNRNPH1P3 is over-expressed in tumor, although a few such as LUSC and THCA show the opposite, repressed pattern.

COAD, LIHC, and LUSC are the cancer types where HNRNPH1P3 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in HNRNPH1P3 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	II,III,IV	+0.289	<.001	7	view →
LIHC	Female	All	+0.029	.021	3	view →
LUSC	Female	II,III,IV	−0.130	.027	2	view →
THCA	All	All	−0.023	.018	2	view →
LUAD	All	All	+0.079	.023	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

HNRNPH1P3–COAD

Open the COAD breakdown →